Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Global measles cases drop 71% in 24 years as vaccination coverage improves, WHO says - 2Instructions to Keep up with Your Traded Teeth for Life span
- 3Full SNAP benefits must be paid ‘promptly,’ USDA tells states as government reopens
- 4College students are now slightly less likely to experience severe depression, research shows – but the mental health crisis is far from over
- 5Invigorating Spots To Go Kayaking All over The Planet
- Evaluated Smartwatches for Wellness Devotees
- ‘RuPaul's Drag Race’ Season 18: How to watch without cable, premiere time, cast list and more
- 6 US States for Fly Fishing
- Tech Devices 2023: The Most blazing Arrivals of the Year
- What to know as New York City nurses strike for a 3rd day
- The race is on to turn your body into a GLP-1 factory
- 7 Powerful Methods for forestalling Telephone Overheating: Keep Your Gadget Cool
- Hamas Navy head, engineer of Khan Yunis tunnel network killed in Gaza, IDF confirms
- Zelensky sees win for Ukraine as EU finally reaches funding deal
